Notably, despite low absolute neutrophil counts from standard-of-care RA DMARD therapy, the percent level of DEspR+CD11b+ neutrophils and NET+Ns are relatively high comparable to %levels seen in ARDS [9] and sICH [10]. This evidence concerns the gene FBXW7-AS1 and rheumatoid arthritis.